Study on the effect of continuous pumping of esketamine on postpartum depression and pain after cesarean section

Status

Active, not recruiting

Phases

Phase 4

Study type

Interventional

Source

ChiCTR

Registry ID

ChiCTR2100047883

Enrollment

Unknown

Registered

2021-06-27

Start date

2021-06-25

Completion date

Unknown

Last updated

2022-03-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

postpartum depression, PPD

Interventions

test group:Fentanyl 1mg + esketamine 50mg + tropisetron 10mg)

Control group:Fentanyl 1mg + Tropisetron 10mg

Eligibility

Sex/Gender

Female

Age

20 Years to 40 Years

Inclusion criteria

Inclusion criteria: 1. 2021.1-2023.1 Parturients undergoing cesarean section in Panzhihua Central Hospital; 2. Maternal aged between 20-40 years old; 3. Gestational age between 37-42 weeks; 4. The birth weight of the fetus is between 2500-4000g.

Exclusion criteria

Exclusion criteria: 1. Having suffered from depression during or before pregnancy; 2. Experienced domestic violence during pregnancy; 3. Serious obstetric complications or serious underlying diseases during pregnancy; 4. The fetus has a genetic disease or congenital disease; 5. Multiple births; 6. Maternal weight 100 kg, and maternal height 180 cm.

Design outcomes

Primary

Measure	Time frame
Postoperative depression evaluation index;	—

Secondary

Measure	Time frame
Postoperative pain evaluation index;	—

Countries

China

Contacts

Public ContactBian Jiang

Panzhihua Central Hospital

5678369@qq.com+86 18096308622

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026